BiotechTube
BlueSphere Bio

BlueSphere Bio

Pittsburgh, United States· Est.
bluespherebio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

BlueSphere Bio is a private, pre-revenue biotech focused on next-generation TCR-T cell therapies for oncology and rare diseases. Its core asset is the TCXpress™ platform, a high-throughput, automated TCR discovery engine designed to identify optimal TCRs against a wide array of targets, including neoantigens. The company is advancing its pipeline through early clinical trials, positioning itself in the competitive but high-potential cell therapy space. Key challenges include clinical execution, platform validation, and navigating a complex regulatory and competitive landscape.

OncologyRare Diseases

Technology Platform

TCXpress™, a proprietary high-throughput, automated TCR discovery platform for rapid screening, identification, and validation of therapeutic T-cell receptors.

Funding History

2
Total raised:$30M
Series A$25M
Seed$5M

Opportunities

The TCR-T therapy market, particularly for solid tumors, represents a major unmet need and large commercial opportunity.
The proprietary TCXpress™ platform could enable faster, more efficient pipeline development and serve as a foundation for valuable strategic partnerships or platform licensing deals.

Risk Factors

High clinical development risk inherent to novel cell therapies, especially in solid tumors.
Significant competition in the TCR-T space from better-funded entities.
Dependency on raising sufficient capital to fund expensive clinical trials and operations as a pre-revenue company.

Competitive Landscape

BlueSphere Bio competes in the rapidly evolving TCR-T therapy arena with companies like Adaptimmune, Immunocore, T-Cure Bioscience, and the cell therapy divisions of large pharmaceutical firms. Differentiation hinges on the speed, efficiency, and output quality of its TCXpress™ discovery platform.

More companies in Cell & Gene Therapy →More companies in United States →